The objective of the poll is to know the variation in agreement or disagreement about the effect of FDA warning on their prescribing habits.
The FDA periodically issues safety warnings or discloses investigations, which about drugs it had previously approved for marketing. But how to apply this new information for individual patients is often left up to clinicians.
In July 2018, FDA recalled several drug products containing the active ingredient valsartan, used to treat high blood pressure and heart failure. This recall was due to an impurity, N-nitrosodimethylamine (NDMA), which was found in the recalled products. In May 2020, FDA issued voluntary recalls of certain extended-release (ER) metformin drugs because the agency’s testing showed NDMA above the acceptable intake limit in certain lots.
Let's find out which type of FDA warning is most likely to influence your prescribing habits?
Also, comment below how this has shown effect in your practice.